Research and Markets (http://www.researchandmarkets.com/research/f82lfs/celiac) has announced the addition of the "Celiac Disease-Pipeline Insights" subscription to their offering.
This Celiac Disease-Pipeline Insights report provides comprehensive insights about pipeline drugs across this indication. A key objective of the report is to establish the understanding for all the pipeline drugs that fall under Celiac Disease.
This report provides information on the therapeutic development based on the Celiac Disease dealing with all the pipeline drugs, comparative analysis at various stages covering Filed, Phase III, Phase II, Phase I, IND filed, Preclinical, Discovery and unknown stages, therapeutics assessment by monotherapy and combination products and molecule type drug information.
The report also covers the companies information involved in the therapeutic development of the products. It also has highlighted the discontinued and dormant products.
Key Topics Covered:
- Celiac Disease Overview
- Celiac Disease Pipeline Therapeutics
- Celiac Disease Therapeutics under Development by Companies
- Celiac Disease Late Stage Products (Filed and Phase III)
- Comparative Analysis
- Celiac Disease Mid Clinical Stage Products (Phase II)
- Comparative Analysis
- Celiac Disease Early Clinical Stage Products (Phase I and IND Filed)
- Comparative Analysis
- Celiac Disease Discovery and Pre-Clinical Stage Products
- Comparative Analysis
- Drug Candidate Profiles
- Celiac Disease - Therapeutics Assessment
- Assessment by Monotherapy Products
- Assessment by Combination Products
- Assessment by Route of Administration
- Assessment by Molecule Type
- Celiac Disease - Discontinued Products
- Celiac Disease - Dormant Products
- Companies Involved in Therapeutics Development for Celiac Disease
- Appendix
For more information visit http://www.researchandmarkets.com/research/f82lfs/celiac